Folgen
Keine Story von NHMRC Clinical Trials Centre - The University of Sydney mehr verpassen.

NHMRC Clinical Trials Centre - The University of Sydney

Filtern
  • 07.11.2007 – 23:07

    Fenofibrate - First Lipid Modifying Agent Shown to Protect Diabetic Eye

    Sydney, November 7 (ots/PRNewswire) - In the Lancet, on Tuesday November, 6th new results of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) 2007 clinical trial have been published and presented on the same date at a press conference held during the AHA. - First lipid modifying agent shown to reduce the need for treatment of the leading ...

  • 06.11.2007 – 01:08

    Fenofibrate - First Lipid Modifying Agent Shown to Protect Diabetic Eye

    Sydney, November 6 (ots/PRNewswire) - - First Lipid Modifying Agent Shown to Reduce Risk of Leading Causes of Blindness and Deteriorating Vision in Patients With Type 2 Diabetes - Reduces Need for Laser Treatment in Patients With and Without Known Diabetic Retinopathy - Significantly Decreases Progression of Diabetic Eye Disease Fenofibrate is the ...